Literature DB >> 14229595

EPITHELIAL AND FIBROEPITHELIAL TUMORS.

H PINKUS.   

Abstract

Keywords:  ADENOCARCINOMA; CARCINOMA, BASAL CELL; CARCINOMA, EPIDERMOID; CLASSIFICATION; DIAGNOSIS, DIFFERENTIAL; EMBRYOLOGY; NEOPLASM DIAGNOSIS; PATHOLOGY; SKIN NEOPLASMS

Mesh：

Year:  1965        PMID： 14229595     DOI： 10.1001/archderm.1965.01600070030003

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  8 in total

1.  [On the enzyme histochemistry of basalioma].

Authors:  K Wolff; K Holubar
Journal:  Arch Klin Exp Dermatol       Date:  1965-12-01

2.  [Morphological patterns of basalioma (author's transl)].

Authors:  M Hundeiker; U Baier; W Krause
Journal:  Arch Dermatol Forsch       Date:  1973

3.  [The presence of giant cells with multiple nuclei in basalioma].

Authors:  M Rupec; F Vakilzadeh; G Korb
Journal:  Arch Klin Exp Dermatol       Date:  1969

4.  [Vascular degeneration in basalioma].

Authors:  M Hundeiker; K Brehm
Journal:  Arch Dermatol Forsch       Date:  1971

5.  Fibroblast-dependent induction of a murine skin lesion with similarity to human common blue nevus.

Authors:  S M Prouty; L Lawrence; K S Stenn
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Case for diagnosis. Fibroepithelioma of Pinkus in a 76-year-old patient.

Authors:  Nicole Baldin; Gabriela Galvão Santos; Paulo Ricardo Martins Souza; Laura Luzzatto
Journal:  An Bras Dermatol       Date:  2022-06-06       Impact factor: 2.113

7.  Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study.

Authors:  Iman Seleit; Ola Ahmed Bakry; Dalia Rifaat Al-Sharaky; Rania Abdel Aziz Ragab; Shimaa Ahmed Al-Shiemy
Journal:  J Clin Diagn Res       Date:  2017-06-01

8.  Gross and microscopic lesions in the female SENCAR mouse skin and lung in tumor initiation and promotion studies.

Authors:  G L Knutsen; R M Kovatch; M Robinson
Journal:  Environ Health Perspect       Date:  1986-09       Impact factor: 9.031
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.